Search results (74)
« Back to NewsAdam Wilkinson wins 2025 ISEH Janet Rowley Award
13 March 2025
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Senior Fellowship awarded to Beth Psaila
28 August 2024
Congratulations to Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
World Cancer Day 2024: Highlighting cancer research at the MRC WIMM
4 February 2024
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
Doug Higgs awarded the 2023 Genetics Society Medal
22 November 2022
The award recognises Professor Higgs' major contribution to our understanding of how mammalian genes are switched on and off, and using haematopoiesis as a model to understand how genes function.
2022 RDM Graduate Prize Winners
3 November 2022
This year's winners are Edward Jenkins, Antje Rottner, and Akshay Shah.
KJ Patel appointed new Chief Scientist of CRUK
12 October 2022
Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).
Wellcome Trust funding success for Jim Hughes and James Davies
9 September 2022
£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.
Six RDM research groups secure LEAF Sustainability Awards
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.
Ewa Gogola receives Wellcome Early Career Award
21 July 2022
Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’
James Davies named as Lister Research Prize Fellow
23 June 2022
James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.